Epi CanaryEpi Canary
  • Home
  • Feed
  • Synthesis
  • Assessments
  • Scopes
  • Reliability
  • Sources
Epi Canary — Epidemic IntelligenceEvidence-led epidemic intelligence. Source-attributed evidence.
Arcede logoMade by Arcede

Public note

For situational awareness and research transparency. Not medical advice.

Novel Pathogen Detectionactive

NDM-producing Enterobacterales prevalence in European ICUs will exceed 5% in EARS-Net 2026 data.

System-generated assessment. This assessment remains under review until the stated horizon or until sufficient evidence allows evaluation.

Emerging confidence

Confidence in this assessment
30%

There are early indications, but the picture is not yet stable. Based on 0 linked evidence items and assessed against Dec 31, 2026.

Assessed through Dec 31, 2026·0 linked evidence items·Tracking since Apr 12, 2026

02

How this assessment will be evaluated

The criteria the system uses to determine whether this assessment is borne out by the stated horizon.

Automated

Method

Evidence Match

The condition the system checks for when evaluating this assessment.

Minimum source quality

T1Primary Institutional

Evidence must meet or exceed this credibility tier to count toward evaluation.

Required terms

enterobacteralesndm-producingprevalenceeuropean

03

Evidence quality mix

Tracking since Apr 12, 2026.

▸Integrity referencesCryptographic hashes for verification

Registration

06

Scope synthesis

The current analyst narrative for this scope.

Open synthesis →

AMR evidence pipeline severely constrained this cycle; two hypotheses resolve Apr 27 without confirmatory data; PubMed failure and stale secondary connectors limit incident coverage.

07

Evidence linked to this assessment

0 linked items.

No linked evidence is available for this assessment yet.

Integrity anchor

Brier 0.202

19 resolved novel pathogen detection predictions.